Illinois Cancer Specialists

Industry News

How Patients Will Respond To Immunomodulator Therapy For Multiple Myeloma

Dec 13, 2011

Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of Mayo Clinic in Arizona. Dr. Stewart presented the results at the 53rd annual meeting of the American Society of Hematology in San Diego... Read More

Novel Experimental Agent Is Highly Active In Chronic Lymphocytic Leukemia Patients, Interim Study Shows

Dec 13, 2011

An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, called PCI-32765, is the first drug designed to target Bruton's tyrosine kinase, a protein essential for CLL-cell survival and proliferation... Read More

Cancer Screening In Older Patients Very Common

Dec 13, 2011

U.S. Preventive Services Task Force guidelines recommend against routine cancer screening, especially for breast, cervical, colorectal and prostate cancer, but adults 75 and older are still receiving regular cancer screenings... Read More

Little-Studied Cellular Mechanism Elevated To Potential Drug Target

Dec 13, 2011

For years, science has generally considered the phosphorylation of proteins -- the insertion of a phosphorous group into a protein that turns it on or off -- as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death... Read More

Study Points To Novel Way To Improve Outcomes From Umbilical Cord Blood Transplants

Dec 13, 2011

A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be pr... Read More

Adults With Hemophilia B Benefit From Gene Therapy

Dec 13, 2011

Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children's Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K... Read More

Nab-Paclitaxel Beats Docetaxel As First-Line Treatment For Metastatic Breast Cancer

Dec 12, 2011

Nab-paclitaxel (Abraxane for Injectable Suspension), at a dose of 150 mg/m2 weekly, improves overall survival (OS) to a much greater degree than conventional taxane monotherapy in women with previously untreated metastatic breast cancer (MBC), according to results of a phase II study released at the 34th Annual San Antonio Breast Cancer symposium (SABCS)... Read More

Prostate Cancer - Cardiovascular Risks Linked To Androgen Suppression Therapy Ignored

Dec 12, 2011

According to specialists' warnings published in Heart, it has been established that androgen suppression therapy (AST) drugs, that suppress testosterone production for the treatment of prostate cancer, can lead to complications in form of stroke and heart disease, yet standard management of the disease ignores this risk... Read More

Screening Finds More Left Sided Bowel Cancers

Dec 12, 2011

Bowel cancer is responsible for 16,000 deaths annually in the UK alone. Bowel cancer is the second leading cause of death in the UK and Europe after lung cancer. The chances of survival are only 50% in the UK, and even remarkably lower in other similar countries... Read More